Basit öğe kaydını göster

dc.contributor.authorAcıpayam, Ahmet
dc.contributor.authorEser, Nadire
dc.contributor.authorYaylalı, Esra Eryılmaz
dc.contributor.authorTülüce, Kerim
dc.contributor.authorYoldaş, Atilla
dc.contributor.authorTolun, Fatma İnanç
dc.date.accessioned2023-09-05T05:39:08Z
dc.date.available2023-09-05T05:39:08Z
dc.date.issued2023en_US
dc.identifier.citationAcıpayam, A., Eser, N., Yaylalı, A.E., Tülüce, K., Yoldaş, A. & Tolun, F.I. (2023). Effect of amifostine on pulmonary contusion from blunt chest trauma in rats. Tropical Journal of Pharmaceutical Research , 22(2), 335-342. http://doi.org/10.4314/tjpr.v22i2.16en_US
dc.identifier.issn1596-5996
dc.identifier.urihttp://doi.org/10.4314/tjpr.v22i2.16
dc.identifier.urihttps://hdl.handle.net/11436/8242
dc.description.abstractPurpose: To investigate the efficacy of different doses of amifostine (AMI) and dexamethasone (DXM) on bilateral pulmonary contusion in rats.Methods: Forty-two Sprague Dawley rats were divided into six groups of seven animals each (control, pulmonary contusion (PC), PC + AMI 400 mg/kg, PC + AMI 200 mg/kg, PC + AMI 400 mg/kg + DXM, and PC + DXM-treated groups). RelAssay commercial kit was used to determine total oxidant status (TOS), total antioxidant status (TAS), and oxidative stress index (OSI). Nitric oxide (NO), inducible nitric oxide synthase (iNOS), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) activity associated with blunt trauma induced pulmonary damage were determined by enzyme -linked immunosorbent assay (ELISA). Blood gas was determined using a blood gas analyzer, while histopathological examinations were performed on the tissues by hematoxylin and eosin (H & E) staining method.Results: Significant improvement in biochemical parameters and histopathological findings were observed in the groups treated with dexamethasone and high-dose amifostine (400 mg/kg; p < 0.05). However, low-dose amifostine (200 mg/kg) and a combination of dexamethasone with amifostine (400 g/kg) was ineffective in balancing the biochemical changes due to trauma (p > 0.05). Conclusion: High-dose amifostine combined with dexamethasone mitigates trauma-induced damage in rat by preventing the elevation of key inflammatory markers. Further preclinical and clinical studies are required to determine the efficacy of amifostine in humans and to compare its activity with other agents.en_US
dc.language.isoengen_US
dc.publisherPharmacotherapyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPulmonary contusionen_US
dc.subjectAmifostineen_US
dc.subjectDexamethasoneen_US
dc.subjectInflammatory markersen_US
dc.subjectChest traumaen_US
dc.titleEffect of amifostine on pulmonary contusion from blunt chest trauma in ratsen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorTülüce, Kerim
dc.identifier.doi10.4314/tjpr.v22i2.16en_US
dc.identifier.volume22en_US
dc.identifier.issue2en_US
dc.identifier.startpage335en_US
dc.identifier.endpage342en_US
dc.relation.journalTropical Journal of Pharmaceutical Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - İdari Personel ve Öğrencien_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster